SpePharm Raises €26M to Spur Further Growth
SpePharm Holding BV closed on a €16 million (US$23.8 million) equity financing round to fund ongoing growth and entered into a €10 million revenue interest acquisition financing agreement related to its purchase of Dantrium for Europe and other markets from Procter & Gamble Pharmaceuticals, a division of P&G, of Cincinnati.
The special pharma company and JHP Pharmaceuticals LLC recently closed on their purchase of Dantrium (Dantrolene Sodium).
Suite: 1100 | Atlanta, Georgia 30346, USA
In the U.S. and Canada: 1-800-477-6307
Outside the U.S.: 1-770-810-3144
In the U.S. and Canada: 1-800-336-4474
Outside the U.S.: 1-215-386-0100
Hours: Monday - Thursday, 8:30 am - 6:00 pm EST
Friday, 8:30am - 4:30 pm EST
Sign up for Perspectives FREE e-mail newsletter